Chemical Biology

Dr. Marie-Ange BADET-DENISOT graduated in biochemistry at P. & M. Curie University (Paris VI) and got her PhD in molecular and cellular pharmacology (1990, P. & M. Curie University) under the guidance of Bernard Badet. Following postdoctoral work with Professor H. Zalkin at Purdue University (USA), she was recruited as a CNRS research associate in 1992 and joined the Chemical Institute of Natural Products in Gif-sur-Yvette in the bioorganic group of Dr. B. Badet. She obtained her HDR in 1999 at P. & M. Curie University. She was named Research Director in 2007. Her research interests are the study of enzyme mechanisms (D-Ala-D-Ala ligase, VanB, VanX, glucosamine-6P synthase Gfat, RMS3) and the elaboration of enzyme inhibitors, at the interface between organic chemistry and biochemistry. The main guideline of the enzymes under study is the elucidation of their catalytic mechanism to design, synthesize and evaluate new inhibitors. Since 2014, she has been involved in the metabolic labeling of bacterial glycan and mammalian cellular glycan as well as in the study of strigolactone receptors.

Dr. Aurélie Baron chemical engineer of CPE Lyon (2005), obtained in 2009 her PhD in organic chemistry from the University Paris-Sud. After she did a two years postdoctoral training under the supervision of Winfried Leibl in the group of Photocatalysis and Biohydrogen (CEA Saclay, iBiTec-S). She joined the ICSN in 2012 as CDD Researcher in the team of Boris Vauzeilles. At the end of 2017, she joined the CNRS as “Ingénieure de Recherche”, within the thematic Probes and Modulators for Biological Targets, in the department of Chemical Biology of the ICSN. She works mainly in the development, the synthesis and the characterization of saccharidic derivatives and molecular tools for the metabolic labeling of glycanes.

Dr. Francois-Didier BOYER is a CNRS researcher (Senior Researcher). He received a chemical engineering degree from ESPCI Paris. He obtained his PhD in 1994 under the supervision of Prof. Jean-Yves Lallemand at the Ecole Polytechnique (Palaiseau, France). After one year postdoctoral training with Pr. Stephen Hanessian from the Université de Montréal, Canada, he joined the INRA (French National Institute of Agricultural Research) in 1995 at Unit for Phytopharmacy and Chemical Mediators (Versailles) in the group of Dr Descoins. He joined the group of Jean-Marie Beau at the Institut de Chimie des Substances Naturelles (ICSN) in June 2008. His current interests concern the synthesis of natural chemical mediators involved in plant growth. Since January 2015 he has been working in the Probes and Modulators for Biological Targets thematic group in the ICSN Chemical Biology Department and joined the CNRS in January 2020. He is currently the coordinator of Scientific Platforms and Services at ICSN.

Dr. Arnaud CHEVALIER received his Ph.D. in bioorganic chemistry in 2014 at the University of Rouen under the co-supervision of Profs. Pierre-Yves Renard and Anthony Romieu. His research works have been focused on the development of new advanced chemical tools for molecular imaging applications especially fluorescence imaging. After a first postdoctoral fellow between 2014 and 2016 under the guidance of Prof. Dr. Sidney M. Hecht at the Arizona State University (United States of America). He joined Dr. Xavier Franck team for an additional post doc dedicated to total synthesis and methodology. In 2017, his last post doc fellow in the Frederic Taran Team at CEA Saclay was focused on radiolabelling and bioconjugation chemistry. Recruited in CNRS as a permanent scientist in October 2018 to wotk in collaboration with Philippe Durand in the Chemical Biology Department at ICSN UPR 2301, his workfield is primarily motivated by the discovery of new methods for the transport and delivery of drugs or imaging agents. organelles such as mitochondria or lysosome.

Dr. Stéphanie DEVILLE-FOILLARD completed a Ph.D. degree in chemistry/biology from Joseph Fourier University (Prof. P. Dumy, 2008, Grenoble), where she was trained in the field of peptide synthesis and molecular engineering. After post-doctoral trainings in nanomedicine on carbon nanotubes (Dr. E. Doris, 2008-2010, CEA Saclay), peptide self-assemblies (Dr. M. Paternostre, 2010-2012, CEA Saclay/IPSEN Les Ulis) and quantum dots (Dr. B. Dubertret, 2012-2013, ESCPI/NextDot Paris), she was appointed by the CNRS as Chargée de Recherche in the chemistry group of Curie Institute (Dr. F. Schmidt, 2013-2017, Paris). She has developed protein conjugates for cancer therapeutic delivery. In January 2017, she joined Chemical Biology Department at the ICSN to work on nanomedicines (gold nanoparticles), molecular MRI contrast agents/radioenhancers (gadolinium chelates) and peptidic/peptidomimetic approaches for medicinal chemistry.

Dr. Philippe DURAND is a CNRS researcher (Research Director). He received his undergraduate degree in chemistry-biochemistry and his Ph.D. in molecular pharmacology from the Paris VI University under the supervision of Prof. François Le GOFFIC and Dr Sames SICSIC in 1985. After his military service as scientist (Percy Hospital), he joined the ISOCHEM company as chemist in 1987 (Custom synthesis) and then moved to FOURNIER company as senior scientist in medicinal chemistry and team manager in 1994 (Pharmaceutical industry). He was recruited as a CNRS research associate in 2001 at ICSN where he was named research director in 2018. His research has been concerned with bioorganic, medicinal chemistries and more recently molecular imaging and chemical biology. The major objective of his more recent research studies has been focused on the study of enzymes mechanism, their inhibition and the in vitro and in vivo detection of their activity. In the latter context, he recently developed, in close collaboration with Eva TOTH’s group (Orléans), new enzyme responsive contrast agents for MRI (T1, paraCEST) /optical imaging.

Dr. Marie-Pierre GOLINELLI is a CNRS Researcher (CR1). After graduating in Chemistry, she did a PhD in Biochemistry under the supervision of Dr J. Meyer (Grenoble) and started to study Fe-S proteins. After 2 years with Prof Sheila S David (U. of Utah, Fe-S protein involved in DNA repair, MutY) and 2 more years with Dr Stephen Hughes (National Cancer Institute, NIH, reverse transcriptase from retroviruses), she was recruited in 2001. She was studying aminoacyl tRNA synthetases and cellular traficking by combining biochemical approches with cellular biology. In 2013, she joined the ICSN. She looks at Fe-S proteins focusing more on the NEET family, proteins acting as redox switch in mammalian cells. Member of the SFBC, SFBBM, COST Fe-S and FrenchBIC.

Dr. Olivier GUITTET is an assistant professor at Université Paris-Saclay. Ha has gratuated in biochemistry and molecular biology before obtaining his PhD degree at université Paris-Sud under the supervision of Dr Michel Lepoivre. He focused on the regulation by nitrogen oxydes of ribonucleotide reductase (RNR), an essential player in deoxyribonucleotide precursors of DNA. He has then studied the transcriptional regualtion of RNRs in Pr Lars Thelander’s group (Umeå University, Sweden). At université Paris-Sud in Michel Lepoivre group he then worked on redox signalling, first by exploring the role of RNRs in resistance to oxidative ans nitrosative stresses, and then on the co-operation between TGF and p73 (a member of the p53 tumor suppressors family) in the regulation of inducible NO synthase expression. He has joined ICSN from 2020 where his interest is on TGF-p73 cooperation in control of redox signalling in the context of fibrotic pathologies. As an assistant professor since 2008, he teaches cell biology at the Licence and Master levels.

Dr. Meng-Er HUANG   is a Research Director at the CNRS. During his early career as hematologist in Shanghai (China), he made a key contribution to the discovery of therapeutic effect of all-trans retinoic acid in the treatment of acute promyelocytic leukemia through induction of differentiation. In 1993, he obtained a PhD degree from the Université Paris-Diderot under the supervision of Dr. Francis Galibert. After a postdoctoral training, he joined CNRS as a junior researcher in 1995. From 2002 to 2005, he worked as a visiting scientist in the laboratory of Prof. Richard Kolodner at Ludwig Institute for Cancer Research at San Diego (California). Supported by a CNRS ATIP program in 2005, he created a new research team in the Institut Curie and led the research projects for better understand oxidative stress-induced genome instability and cell death, and redox-based mechanisms of anticancer molecules. He has joined the ICSN since 2020 in order to constitute a strong group that work on several aspects of redox biology. In this new scientific environment, he is continuously focusing on exploiting oxidative stress- and redox-based anticancer therapeutic strategy in leukemia, breast and lung cancer models.

Dr. Michel LEPOIVRE is a Research Director at the CNRS. He has a strong expertise in the field of redox signaling and oxidative stress. After academic training in biochemistry and enzymology, he completed his PhD thesis in the laboratory of Jean-François Petit at the University Paris-Sud, where he studied the anti-tumor properties of activated type I macrophages in relationship with the production of reactive oxygen species by NADPH oxidase 2. After his recruitment at the CNRS in 1986, he began an in-depth investigation of the cytotoxicity of macrophage-derived nitric oxide (NO), focusing more specifically on the inhibition by NO of ribonucleotide reductase (Rnr), a crucial enzyme crucial for DNA synthesis and tumor cell replication. During this period, he also developed collaborative works with chemists to discover new nucleoside analogues inhibiting Rnr, a pharmacological target for anti-cancer and anti-viral treatments. Appointed Research Director in 1997, he began to manage a research team at Paris-Sud University in 2005. Since 2009, he has been interested in the functional interactions between NO and p73, one of the three members of the p53 suppressor family. In particular, he unveiled a synergy between p73 and TGF-β in the downregulation of the NOS2 gene encoding inducible NO synthase in fibroblasts. In 2020, he joined ICSN to study the role of p73 in the production of reactive oxygen species dependent on the TGF-β signaling pathway and involved in fibrotic pathologies.

Emilie MEROUR is an Engineer at ICSN since November 2023. She joined the CIBI platform (D5) at 50% under the direction of Dr. Bignon and the redox team (D3) at 50% under the direction of Dr. Golinelli -Cohen. After training at the IUT biological and biochemical analyzes in Brest, she continued her studies with a professional Master’s degree in Physiology and Cellular and Molecular Biology in Poitiers. After a 9-month engineering internship within the company CRO Charles River (CitoxLab), a company evaluating drug candidates particularly in the preclinical phase, she completed several fixed-term contracts within INSERM teams studying chronic inflammatory diseases of the intestine under the direction of Professor Desreumaux (Lille) and then viral hepatitis under the direction of Professor Pawlotsky (Créteil). In 2008, after an INRAE competition, she joined INRAE center of ​​Jouy en Josas within the fish molecular virology team under the direction of Dr Brémont and then Dr Biacchesi. For 15 years, she studied virulence mechanisms both concerning viruses and also resulting from host-pathogen interaction via the innate immune response, with the aim of developing new knowledge about these viruses and developing vaccine strategies to protect fish farms from infections. This work has been the subject of numerous publications but also the filing of patents. In 2023, after a request for internal mobility, Emilie was recruited at the CNRS at the ICSN. She works within the CIBI platform for which she carries out cellular screenings, high-throughput robotic screenings and biochemical analyzes of proteins. As part of the redox team which studies the NEET family proteins involved in particular in the regulation of iron metabolism and cell redox, she is developing an protein-protein interactions approach based on the use of BioID biotin ligase in order to to identify potential partners and better understand their functioning within the cell.

Dr. Stephanie NORSIKIAN received a Ph.D. degree from the Université of Paris VI in 1999, under the supervision of Professors J.-F. Normant and I. Marek. After post-doctoral trainings in the groups of Professor D.M. Hodgson (Oxford, U.K), Professor G. Guillaumet (Orléans, France) and Professor H. Kagan (Orsay, France), she was appointed by the CNRS as Chargée de Recherche in 2002 in the group of Professor A. Lubineau (Orsay). In January 2007, she joined Professor J.-M. Beau’s group at the Institut de Chimie des Substances Naturelles (ICSN in Gif sur Yvette). Since January 2015, she has been working in the team “Probes and Modulators for Biological Targets” (Chemical-Biology Department-ICSN). In 2022, she has been promoted Research Director and became assistant coordinator of the Chemical Biology department of ICSN. Her research interests focus mainly on glycochemistry and synthesis of biomolecules but also on organometallic chemistry, multicomponent reactions and fluorescent probes.

Dr. Boris VAUZEILLES is a CNRS researcher (Senior Researcher). He is the director of the Institut de Chimie des Substances Naturelles (ICSN) in Gif-sur-Yvette. As a student, he joined the Ecole Normale Supérieure in 1990, where he obtained in 1996 a PhD degree from Université Pierre et Marie Curie, under the supervision of Prof. Pierre Sinaÿ. He then moved to Cambridge, Massachussets, for a post-doctoral stay at MIT with Prof. Julius Rebek, Jr, and followed the group, which soon relocated to the Scripps Research Institute in La Jolla (California). He joined CNRS as a researcher in 1998, in the group of Prof. Jean-Marie Beau in Orsay (Institut de Chimie Moléculaire et des Matériaux d’Orsay (ICMMO), Université Paris-Sud). In 2006 he became the leader of a small group focusing on Glycomimetics and Recognition. In 2012 he was offered the opportunity to create, in parallel with this activity in Orsay, a new team at ICSN. At the end of 2014 he became the co-founder of a startup company, Click4Tag. His research interests focus on the application of synthetic chemistry to the development of molecular probes to investigate biological processes. This includes synthetic glycochemistry and the synthesis of bioactive carbohydrate analogues and glycoconjugates, the development of eco-friendly chemistry using biomass as a starting material, studies towards artificial photosynthesis, as well as metabolic glycan labeling of living bacteria.

He is the Director of the ICSN since early 2020.

Dr. Laurence VERNIS is a Research Scientist at INSERM. She received a Master Degree in Agricultural Sciences from the National Institute for Agricultural Sciences (INAPG) together with Paris Sud University, and received her PhD in microbiology on the study of autonomously replicating plasmids in the dimorphic yeast Yarrowia lipolytica. After two post-doctoral positions working on secretion and DNA replication using various yeast models, she was appointed  by INSERM at the Institut Curie in Orsay, focusing on DNA replication and genomic instability. In 2020, she joined ICSN to study redox regulations of genomic instability in a dedicated scientific environment.

Dr. Sébastien VIDAL received his PhD in organic chemistry in 2000 (University of Montpellier, France – Prof. Jean-Louis Montero and Prof. Alain Morère) on the synthesis of mannose 6-phosphate analogues. He then moved to UCLA with Sir J. Fraser Stoddart (Nobel Prize in Chemistry 2016) to study glycodendrimers. In 2003, he joined NREL (Golden, Colorado) with Prof Joseph Bozell and studied the combination of organometallic and carbohydrate chemistries. He obtained a CNRS position at University of Lyon in 2004 and started his own projects on carbohydrate chemistry and applications in biology. He has now joined the Institut de Chimie des Substances Naturelles.

Orane BENOIT graduated from ENSCM (École Nationale Supérieure de Chimie de Montpellier) in 2023 with a degree in chemical engineering, specializing in chemistry, biology and health. In the same year, she completed a double degree course at the Montpellier Faculty of Pharmacy and obtained a master’s degree in Chemistry Biology in the Medicinal Translational Chemistry specialization. She has been working on her thesis at ICSN since October 2023, under the supervision of Dr. Marie-Pierre GOLINELLI, entitled “Study of the role of human NEET family proteins in breast cancer”.

Dr. Hugo BLOUX obtained his PhD in 2022 at the University of Caen. He worked under the direction of Dr. Thomas Cailly and Pr. Frédéric Fabis on the development of new methodologies of radiolabelling using iodine-125 on aromatic substrates. He came to the ICSN in 2023 for working under the direction of Dr. Stéphanie Norsikian as research engineer for two years. His project, funded by the ANR 2021 – BORIPROBE, is the synthesis of borinic acids as probes for the detection of hydrogen peroxide on cells.

Delphine CARRY obtained her Master Degree in Organic Chemistry for the Living in 2021 from the University of Poitiers. She then joined the ICSN as a research engineer under the supervision of Drs Stéphanie Norsikian and Sébastien Vidal. Initially, she worked on the gram-scale synthesis of three regioisomeric tetrasaccharides composed of glucoside units in collaboration with Elicityl. She is currently working on the development of saccharide precursors for their deuteration and functionalization as part of the ANR project Glyco-CD in collaboration with Dr Sophie Feuillastre (CEA Saclay).

Fiona CESARIN is a research engineer at the CNRS. Following a BTS in Biotechnologies and a Licence Professionnelle in Bio-Industries and Biotechnologies (Université Paris-Saclay), she obtained a Master’s degree in Biology-Health (BIOTIN, Université de Montpellier) in 2022. She is currently involved in the Sulfo-tRNA project, where she is studying the TRMU protein in particular.

Victor CRESPIN obtained his engineering diploma in 2021 from the ESCPE School in Lyon. He spent one year in Origenis GmbH laboratories, as an internship between his 4th and 5th year of engineering school, where he synthesized potentially bioactives compounds against Parkinson disease. He did his last year of engineering school at the University College of London as an Erasmus student where he specialized in organic and medicinal chemistry. During his final year internship, he synthesized diazo-infraluciferin compounds to explore bioluminescence and was at UCL under the supervision of Prof. Jim Anderson. He is currently doing a PhD at ICSN, under the supervision of Dr. Sebastien Vidal, with the following subject: « Steresolective synthesis via nickel catalysis of C-aryl glycoside as potentially diabetes and/or anti-infectives therapy ».

Suzanne DAIGNAN FORNIER de LACHAUX has obtained in 2019 her diploma from ENSIACET (Ecole Nationale Supérieure des Ingénieurs en Arts Chimiques Et Technologiques) in Toulouse. She is a PhD student at the ICSN, supervised by Dr. François-Didier Boyer. Her subject is “Hemp strigolactone synthesis, development of marked standards for its quantification in hemp exudates or in planta “.

Clara De La TRAMBLAIS obtained iher Master’s degree in Pharmaceutical Chemistry at Paris Saclay University in 2023. She carried out her end-of-study internship at the Institut Galien Paris-Saclay entitled ” Development of nanomedicines for cardiac therapy: analytical development and production » under the supervision of Prof. Mariana Varna. She has been carrying out her thesis at ICSN since October 2023 under the supervision of Dr. Sébastien Vidal, with the subject “Dynasweet – Glycoclusters and dynamic combinatorial chemistry towards multivalent lectin ligands as potential antibacterial agents”.

Dr. Sophia GODEL-PASTRE, a pharmacist and chemist by training, obtained her PhD in Chemistry in 2022. Her PhD work, carried out at CEA Paris Saclay and supervised by Dr. Edmond Gravel, focused on the synthesis and functionalization of organic and metallic nanoparticles and the evaluation of their in vitro therapeutic potential as adjuvants in radiotherapy. Sophia is now undertaking a 2-year post-doctorate at ICSN, where she is working on the development of new radiosensitization strategies.

Jolimar HANNA obtained in 2022 the Master’s degree in Health Biology (Metabolic and Chronic Diseases) / Molecular Diagnostics, from the University of Reunion with a course in Biochemistry. She has been doing her thesis at ICSN since October 2022 under the supervision of Dr. Michel LEPOIVRE and Dr. Meng-Er HUANG, with the subject: “the analysis of the early effects of oxidative stress induced by auranofin, a gold complex with promising anticancer activities”

Zhiliang HEI is a doctoral candidate at the University of Paris-Saclay. After completing his master’s thesis in China, he received funding from the China Scholarship Council in 2020. He is currently studying anti-cancer treatment strategies based on oxidative stress and redox under the guidance of Dr. Meng-Er Huang.

Dr. Antoinette KEITA completed her PhD. in Chemistry, speciality Chemistry-Biology, at the Université Paris Cité in March 2022 under the co-direction of Pr. François-Hugues PORÉE and Dr. Romain DUVAL. Her thesis work focused on the search for new antimalarial drugs targeting the hepatic phase of Plasmodium falciparum: search for simplified analogues of tazopsin series. Antoinette is currently a postdoctoral researcher at the Institute of Chemistry of Natural Substances in the Chemobiology Department under the supervision of Dr. François-Didier BOYER

Laurane MICHEL obtained an Engineer diploma, specialised in molecular chemistry at the ECPM (European Engineering School of Chemistry, Polymer and Materials), Strasbourg, in 2021. She also obtained the same year a Master degree “Molecular and Supramolecular Chemistry” at the University of Strasbourg. She started in January 2022 a PhD at the ICSN under the supervision of Dr Arnaud Chevalier and Dr Philippe Durand, entitled “Activable platforms by an enzyme for the selective release of drugs in the mitochondria”.

Anna PORCHER obtained his engineering degree graduated in organic chemistry from ENSCR (Ecole Nationale Supérieure de Chimie de Rennes) in 2019. She also obtained a Master of Research in Molecular Chemistry from University Rennes 1. Then, she worked as a research engineer at the CEA. First, at SIMoS (Service d’Ingénierie Moléculaire pour la Santé) with Dr. Laurent Devel in partnership with Institut Pasteur, on the development of chemical probes for the identification of protein targets of a broad-spectrum toxin inhibitor. Then, at the SCBM (Service de Chimie Biiorganique et de Marquage) with Dr. Eric Doris and Dr. Edmond Gravel, on the development of a new diagnostic approach based on the production of synthetic biomarkers and their detection in urine. She is currently working as a research engineer in Dr. Sébastien Vidal’s team, in collaboration with Dr. Julien Nicolas at the Institut Galien, on the development of dynamic glycosylated polymers as potential antibacterial agents.

Baptiste SCHELLE obtained his engineering degree in chemistry and chemical engineering from École Supérieure de Chimie Physique Électronique de Lyon (ESCPE Lyon) in 2021. He also obtained a Master of Research form Université Claude Bernard Lyon 1 (UCBL) to specialize himself in organic chemistry. He has done internsip abroad in Karlsruhe Institute für Technologie (KIT) where he studied Buchwald-Hartwig amination as well as Ugi multicomponent reaction. He also worked for Monash Institute of Pharmaceutical Sciences (MIPS) in Melbourne where he developped new monomers for drug encapsulation and delivery. Currently, he holds a position as a PhD student at ICSN in the Boyer group under the supervision of Dr. Norsikian. He works towards the first total synthesis of natural compounds comprising rare sugars. These compounds are expected to play a role in the rising antibiotics resistance crisis. Outside the lab, his interests are the following : cycling, traveling, skiiing, art, cinema, live music as well as computer sciences

Eléonore TACKE obtained in 2021 the Master’s degree in Chemistry from Sorbonne University with a course in Molecular Chemistry. She has been doing her PhD at the ICSN since October 2021 under the supervision of Dr. Arnaud Chevalier and Dr. Philippe Durand, with the subject of the functionalization of luminescent aromatic heterocycles.

Dr. Cindy VALLIERES completed her PhD under the supervision of Brigitte Meunier (I2BC, Gif-sur-Yvette) in 2012. Her PhD project focused on the complex III of the mitochondrial respiratory chain. She then joined, as a research fellow, Pr Simon Avery’s lab (University of Nottingham, UK) where she elaborated novel antifungal strategies and started to develop a strong interest in Fe-S proteins as therapeutic targets. In 2020, she was recruited as a senior research scientist by the startup Phenotypeca based at the Biodiscovery Institute and BioCity in Nottingham. After obtaining a Marie Sklodowska-Curie Fellowship, she joined the ICSN to pursue her work on Fe-S proteins. She is studying the functions of the mitochondrial ferredoxin and the molecular mechanisms underlying its biogenesis in order to provide a better understanding of this essential protein and to establish its potential as a new antifungal target.